DALLA PALMA, ANNA BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 406
AS - Asia 114
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.016
Nazione #
US - Stati Uniti d'America 480
SE - Svezia 127
IE - Irlanda 94
CN - Cina 88
IT - Italia 76
DE - Germania 28
AT - Austria 15
FR - Francia 15
TR - Turchia 14
FI - Finlandia 13
RO - Romania 12
CA - Canada 9
BE - Belgio 8
SG - Singapore 8
GB - Regno Unito 5
IN - India 3
SC - Seychelles 3
UA - Ucraina 3
CZ - Repubblica Ceca 2
EU - Europa 2
NL - Olanda 2
RU - Federazione Russa 2
BG - Bulgaria 1
BZ - Belize 1
KH - Cambogia 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
RS - Serbia 1
Totale 1.016
Città #
Chandler 132
Dublin 94
Ann Arbor 57
Ashburn 48
New York 26
Beijing 21
Shanghai 20
Dearborn 19
Parma 19
Bremen 16
Princeton 16
Vienna 15
Wilmington 13
Izmir 12
Helsinki 10
Nanjing 10
Brussels 8
Des Moines 7
San Mateo 7
Fairfield 6
Focsani 6
Romainville 6
Shenyang 6
Toronto 6
Woodbridge 6
Modena 5
Rho 4
Savignano sul Rubicone 4
West Jordan 4
Boardman 3
Bologna 3
Cesena 3
Guangzhou 3
Hangzhou 3
Hebei 3
Jinan 3
Los Angeles 3
Milan 3
Nanchang 3
Norwalk 3
Reggio Emilia 3
Seattle 3
Arcevia 2
Borås 2
Changsha 2
Cornaredo 2
Florence 2
Fremont 2
Jacksonville 2
Kocaeli 2
Marseille 2
Ottawa 2
Piacenza 2
Pune 2
Taiyuan 2
Tianjin 2
Washington 2
Amsterdam 1
Aosta 1
Augusta 1
Belgrade 1
Belize City 1
Castelfranci 1
Castelfranco Emilia 1
Charlotte 1
Chengdu 1
Denver 1
Edinburgh 1
Hefei 1
Huizen 1
Jiaxing 1
Kunming 1
Lagos 1
Leawood 1
Lille 1
Luxembourg 1
Manchester 1
Monmouth Junction 1
Montesilvano 1
Naples 1
Nerviano 1
Oslo 1
Paris 1
Phnom Penh 1
Phoenix 1
Rockville 1
Rome 1
Sofia 1
Taizhou 1
Tampa 1
Turku 1
Verona 1
Wuhan 1
Zhengzhou 1
Totale 709
Nome #
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 89
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 83
Novel targets for the treatment of relapsing multiple myeloma 77
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 73
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 71
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 69
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 65
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 64
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 63
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 55
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 53
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents 50
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 49
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 48
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 46
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results 45
The impact of CD56 expression in smoldering myeloma patients on early progression 30
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 18
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 5
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 4
CD38 expression by plasma cells in extramedullary multiple myeloma 3
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 2
Totale 1.062
Categoria #
all - tutte 4.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 18 1
2019/2020106 11 5 2 3 7 18 13 2 20 18 5 2
2020/2021125 4 3 6 3 29 3 12 13 14 14 9 15
2021/2022134 2 5 9 12 1 2 26 18 6 3 12 38
2022/2023482 62 58 36 42 42 48 24 21 109 11 18 11
2023/2024176 8 17 3 4 22 71 19 7 6 14 5 0
Totale 1.062